Author Correction: Inferring structural variant cancer cell fraction
Marek Cmero(The Royal Melbourne Hospital), S. Cenk Şahinalp(Endeavor Health), Clemency Jolly(The Francis Crick Institute), Cheng Soon Ong(Australian National University), Ruben M. Drews(GlaxoSmithKline (United Kingdom)), Ke Yuan(Shenzhen Maternity and Child Healthcare Hospital), Iñigo Martincorena(Wellcome Sanger Institute), David D.L. Bowtell(The University of Melbourne), Quaid Morris(Kettering University), Elizabeth L. Christie(Peter MacCallum Cancer Centre), Henry Lee-Six(Great Ormond Street Hospital), Rameen Beroukhim(Broad Institute), Roland Eils(Heidelberg University), Pavana Anur, Salem Malikić(Simon Fraser University), Shaolong Cao(The University of Texas MD Anderson Cancer Center), Amit G. Deshwar(Ontario Genomics), Ignaty Leshchiner(Broad Institute), Lara Jerman(Endeavor Health), Matthew W. Fittall(University College Hospital), Martin Peifer(University of Cologne), Yupeng Cun(Children's Hospital of Chongqing Medical University), Dale W. Garsed(Peter MacCallum Cancer Centre), Yuan Ji(Chicago Department of Public Health), Stefan C. Dentro(The Francis Crick Institute), Kerstin Haase(The Francis Crick Institute), Thomas J. Mitchell(University of Cambridge), JuHee Lee(Korea Institute of Toxicology), Peter J. Campbell(Wellcome Sanger Institute), Kevin J. Dawson(Wellcome Sanger Institute), Jan Schröder(The University of Melbourne), Gad Getz(Broad Institute), Myron Peto(Oregon Health & Science University), Dimitri Livitz(Broad Institute)
Cited by 0
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k